Stock Track | Cellebrite Soars 6.43% Pre-market on Strong Q2 Results and New CEO Appointment

Stock Track
2025/08/14

Cellebrite (CLBT) stock surged 6.43% in pre-market trading on Thursday following the release of its impressive second-quarter 2025 financial results and the announcement of a new CEO. The digital intelligence solutions provider demonstrated robust growth across key financial metrics, surpassing analyst expectations in several areas.

The company reported Q2 revenue of $113.276 million, exceeding the IBES estimate of $112.2 million. This represents an 18% year-over-year increase. Notably, Cellebrite's subscription revenue saw a significant 21% rise to $103.0 million, while its Annual Recurring Revenue (ARR) grew by 21% to $418.9 million. The adjusted EBITDA came in at $27.885 million, also surpassing the IBES estimate of $27 million, with an impressive margin of 24.6%.

Adding to the positive news, Cellebrite announced the appointment of Thomas E. Hogan as its new CEO. Hogan expressed confidence in the company's growth trajectory and its ability to support customers in law enforcement, defense, and intelligence sectors. The combination of strong financial performance and new leadership seems to have bolstered investor confidence, driving the stock's pre-market rally.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10